PMC:7242185 / 5289-6332 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T29","span":{"begin":142,"end":147},"obj":"Disease"},{"id":"T30","span":{"begin":201,"end":206},"obj":"Disease"},{"id":"T31","span":{"begin":249,"end":253},"obj":"Disease"},{"id":"T32","span":{"begin":443,"end":448},"obj":"Disease"},{"id":"T33","span":{"begin":544,"end":549},"obj":"Disease"},{"id":"T34","span":{"begin":791,"end":794},"obj":"Disease"},{"id":"T36","span":{"begin":931,"end":934},"obj":"Disease"}],"attributes":[{"id":"A29","pred":"mondo_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/MONDO_0041656"},{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0041656"},{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"},{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0041656"},{"id":"A33","pred":"mondo_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/MONDO_0041656"},{"id":"A34","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0005010"},{"id":"A35","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0018922"},{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"}],"text":"Group 2019162 patients Group 202084 patients P value Group I 2019162 patients Group II 202084 patients P value\nAGE 69.9 + 32.6 68.3 + 30.9 ns STEMI 59 (36.4%) 34 (40.5%) ns\nSEX M:113/F:49 M:62/F:22 ns STEMI rr \u003e 24 hours 7 (4.3%) 15 (17.8%) \u003c 0.001\nCOPD 35 (21.6%) 7 (8.3%) \u003c 0.01 NSTEMI 93 (57.4%) 33 (39.3%) \u003c 0.01\nHYPERTENSION 108 (66.7%) 65 (77.4%) ns Others ACS 3 (1.9%) 2 (2.4%) \u003c 0.01\nDIABETES 48 (29.6%) 31 (36.9%) ns Door to balloon (STEMI) 40 + 12 (minutes) 66 + 17 (minutes) \u003c 0.001\nSMOKING 85 (52.5%) 34 (40.5%) ns Symptoms to PCI (STEMI) 3.9 + 2.2 (hours) 5.8 + 3.1 (hours) \u003c 0.001\nDYSLIPIDEMIA 100 (61.7%) 58 (69%) ns Symptoms to PCI (NSTEMI) 18.8 + 20 (hours) 36.9 + 38.4 (hours) \u003c 0.001\nBMI \u003e 30 36 (22.2%) 23 (27.4%) ns hs-cTnI (basal) 1142 + 4017 5138 + 9408 \u003c 0.001\nKNOWN CAD 41 (25.3%) 31 (36.9%) ns hs-cTnI (peak) 9143 + 13,825 13,681 + 10,936 \u003c 0.01\nAF 18 (11.1%) 6 (7.1%) ns LVEF 48.9 + 9.4 45.9 + 12 \u003c 0.05\nCKD 21 (13%) 12 (14.3%) ns LVEF \u003c 40% 24.7% 42.8% \u003c 0.01\nGRACE SCORE 116 + 26 126 + 27 \u003c 0.01 Death 1.8% 4.7% ns"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T23","span":{"begin":159,"end":161},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"},{"id":"T24","span":{"begin":195,"end":197},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T25","span":{"begin":254,"end":256},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T26","span":{"begin":401,"end":403},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T27","span":{"begin":513,"end":515},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"},{"id":"T28","span":{"begin":712,"end":714},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"},{"id":"T29","span":{"begin":795,"end":797},"obj":"http://purl.obolibrary.org/obo/CLO_0053794"},{"id":"T30","span":{"begin":875,"end":877},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T31","span":{"begin":1000,"end":1003},"obj":"http://purl.obolibrary.org/obo/CLO_0001046"},{"id":"T32","span":{"begin":1015,"end":1017},"obj":"http://purl.obolibrary.org/obo/CLO_0050509"}],"text":"Group 2019162 patients Group 202084 patients P value Group I 2019162 patients Group II 202084 patients P value\nAGE 69.9 + 32.6 68.3 + 30.9 ns STEMI 59 (36.4%) 34 (40.5%) ns\nSEX M:113/F:49 M:62/F:22 ns STEMI rr \u003e 24 hours 7 (4.3%) 15 (17.8%) \u003c 0.001\nCOPD 35 (21.6%) 7 (8.3%) \u003c 0.01 NSTEMI 93 (57.4%) 33 (39.3%) \u003c 0.01\nHYPERTENSION 108 (66.7%) 65 (77.4%) ns Others ACS 3 (1.9%) 2 (2.4%) \u003c 0.01\nDIABETES 48 (29.6%) 31 (36.9%) ns Door to balloon (STEMI) 40 + 12 (minutes) 66 + 17 (minutes) \u003c 0.001\nSMOKING 85 (52.5%) 34 (40.5%) ns Symptoms to PCI (STEMI) 3.9 + 2.2 (hours) 5.8 + 3.1 (hours) \u003c 0.001\nDYSLIPIDEMIA 100 (61.7%) 58 (69%) ns Symptoms to PCI (NSTEMI) 18.8 + 20 (hours) 36.9 + 38.4 (hours) \u003c 0.001\nBMI \u003e 30 36 (22.2%) 23 (27.4%) ns hs-cTnI (basal) 1142 + 4017 5138 + 9408 \u003c 0.001\nKNOWN CAD 41 (25.3%) 31 (36.9%) ns hs-cTnI (peak) 9143 + 13,825 13,681 + 10,936 \u003c 0.01\nAF 18 (11.1%) 6 (7.1%) ns LVEF 48.9 + 9.4 45.9 + 12 \u003c 0.05\nCKD 21 (13%) 12 (14.3%) ns LVEF \u003c 40% 24.7% 42.8% \u003c 0.01\nGRACE SCORE 116 + 26 126 + 27 \u003c 0.01 Death 1.8% 4.7% ns"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T7","span":{"begin":84,"end":86},"obj":"Chemical"},{"id":"T8","span":{"begin":111,"end":114},"obj":"Chemical"},{"id":"T9","span":{"begin":872,"end":874},"obj":"Chemical"}],"attributes":[{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_84123"},{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_73807"}],"text":"Group 2019162 patients Group 202084 patients P value Group I 2019162 patients Group II 202084 patients P value\nAGE 69.9 + 32.6 68.3 + 30.9 ns STEMI 59 (36.4%) 34 (40.5%) ns\nSEX M:113/F:49 M:62/F:22 ns STEMI rr \u003e 24 hours 7 (4.3%) 15 (17.8%) \u003c 0.001\nCOPD 35 (21.6%) 7 (8.3%) \u003c 0.01 NSTEMI 93 (57.4%) 33 (39.3%) \u003c 0.01\nHYPERTENSION 108 (66.7%) 65 (77.4%) ns Others ACS 3 (1.9%) 2 (2.4%) \u003c 0.01\nDIABETES 48 (29.6%) 31 (36.9%) ns Door to balloon (STEMI) 40 + 12 (minutes) 66 + 17 (minutes) \u003c 0.001\nSMOKING 85 (52.5%) 34 (40.5%) ns Symptoms to PCI (STEMI) 3.9 + 2.2 (hours) 5.8 + 3.1 (hours) \u003c 0.001\nDYSLIPIDEMIA 100 (61.7%) 58 (69%) ns Symptoms to PCI (NSTEMI) 18.8 + 20 (hours) 36.9 + 38.4 (hours) \u003c 0.001\nBMI \u003e 30 36 (22.2%) 23 (27.4%) ns hs-cTnI (basal) 1142 + 4017 5138 + 9408 \u003c 0.001\nKNOWN CAD 41 (25.3%) 31 (36.9%) ns hs-cTnI (peak) 9143 + 13,825 13,681 + 10,936 \u003c 0.01\nAF 18 (11.1%) 6 (7.1%) ns LVEF 48.9 + 9.4 45.9 + 12 \u003c 0.05\nCKD 21 (13%) 12 (14.3%) ns LVEF \u003c 40% 24.7% 42.8% \u003c 0.01\nGRACE SCORE 116 + 26 126 + 27 \u003c 0.01 Death 1.8% 4.7% ns"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T6","span":{"begin":249,"end":253},"obj":"Phenotype"},{"id":"T7","span":{"begin":317,"end":329},"obj":"Phenotype"},{"id":"T8","span":{"begin":595,"end":607},"obj":"Phenotype"}],"attributes":[{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0006510"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0000822"},{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0003119"}],"text":"Group 2019162 patients Group 202084 patients P value Group I 2019162 patients Group II 202084 patients P value\nAGE 69.9 + 32.6 68.3 + 30.9 ns STEMI 59 (36.4%) 34 (40.5%) ns\nSEX M:113/F:49 M:62/F:22 ns STEMI rr \u003e 24 hours 7 (4.3%) 15 (17.8%) \u003c 0.001\nCOPD 35 (21.6%) 7 (8.3%) \u003c 0.01 NSTEMI 93 (57.4%) 33 (39.3%) \u003c 0.01\nHYPERTENSION 108 (66.7%) 65 (77.4%) ns Others ACS 3 (1.9%) 2 (2.4%) \u003c 0.01\nDIABETES 48 (29.6%) 31 (36.9%) ns Door to balloon (STEMI) 40 + 12 (minutes) 66 + 17 (minutes) \u003c 0.001\nSMOKING 85 (52.5%) 34 (40.5%) ns Symptoms to PCI (STEMI) 3.9 + 2.2 (hours) 5.8 + 3.1 (hours) \u003c 0.001\nDYSLIPIDEMIA 100 (61.7%) 58 (69%) ns Symptoms to PCI (NSTEMI) 18.8 + 20 (hours) 36.9 + 38.4 (hours) \u003c 0.001\nBMI \u003e 30 36 (22.2%) 23 (27.4%) ns hs-cTnI (basal) 1142 + 4017 5138 + 9408 \u003c 0.001\nKNOWN CAD 41 (25.3%) 31 (36.9%) ns hs-cTnI (peak) 9143 + 13,825 13,681 + 10,936 \u003c 0.01\nAF 18 (11.1%) 6 (7.1%) ns LVEF 48.9 + 9.4 45.9 + 12 \u003c 0.05\nCKD 21 (13%) 12 (14.3%) ns LVEF \u003c 40% 24.7% 42.8% \u003c 0.01\nGRACE SCORE 116 + 26 126 + 27 \u003c 0.01 Death 1.8% 4.7% ns"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T36","span":{"begin":0,"end":110},"obj":"Sentence"},{"id":"T37","span":{"begin":111,"end":172},"obj":"Sentence"},{"id":"T38","span":{"begin":173,"end":248},"obj":"Sentence"},{"id":"T39","span":{"begin":249,"end":316},"obj":"Sentence"},{"id":"T40","span":{"begin":317,"end":391},"obj":"Sentence"},{"id":"T41","span":{"begin":392,"end":493},"obj":"Sentence"},{"id":"T42","span":{"begin":494,"end":594},"obj":"Sentence"},{"id":"T43","span":{"begin":595,"end":702},"obj":"Sentence"},{"id":"T44","span":{"begin":703,"end":784},"obj":"Sentence"},{"id":"T45","span":{"begin":785,"end":871},"obj":"Sentence"},{"id":"T46","span":{"begin":872,"end":930},"obj":"Sentence"},{"id":"T47","span":{"begin":931,"end":987},"obj":"Sentence"},{"id":"T48","span":{"begin":988,"end":1043},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Group 2019162 patients Group 202084 patients P value Group I 2019162 patients Group II 202084 patients P value\nAGE 69.9 + 32.6 68.3 + 30.9 ns STEMI 59 (36.4%) 34 (40.5%) ns\nSEX M:113/F:49 M:62/F:22 ns STEMI rr \u003e 24 hours 7 (4.3%) 15 (17.8%) \u003c 0.001\nCOPD 35 (21.6%) 7 (8.3%) \u003c 0.01 NSTEMI 93 (57.4%) 33 (39.3%) \u003c 0.01\nHYPERTENSION 108 (66.7%) 65 (77.4%) ns Others ACS 3 (1.9%) 2 (2.4%) \u003c 0.01\nDIABETES 48 (29.6%) 31 (36.9%) ns Door to balloon (STEMI) 40 + 12 (minutes) 66 + 17 (minutes) \u003c 0.001\nSMOKING 85 (52.5%) 34 (40.5%) ns Symptoms to PCI (STEMI) 3.9 + 2.2 (hours) 5.8 + 3.1 (hours) \u003c 0.001\nDYSLIPIDEMIA 100 (61.7%) 58 (69%) ns Symptoms to PCI (NSTEMI) 18.8 + 20 (hours) 36.9 + 38.4 (hours) \u003c 0.001\nBMI \u003e 30 36 (22.2%) 23 (27.4%) ns hs-cTnI (basal) 1142 + 4017 5138 + 9408 \u003c 0.001\nKNOWN CAD 41 (25.3%) 31 (36.9%) ns hs-cTnI (peak) 9143 + 13,825 13,681 + 10,936 \u003c 0.01\nAF 18 (11.1%) 6 (7.1%) ns LVEF 48.9 + 9.4 45.9 + 12 \u003c 0.05\nCKD 21 (13%) 12 (14.3%) ns LVEF \u003c 40% 24.7% 42.8% \u003c 0.01\nGRACE SCORE 116 + 26 126 + 27 \u003c 0.01 Death 1.8% 4.7% ns"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"62","span":{"begin":740,"end":744},"obj":"Gene"},{"id":"63","span":{"begin":823,"end":827},"obj":"Gene"},{"id":"64","span":{"begin":363,"end":368},"obj":"Gene"},{"id":"65","span":{"begin":14,"end":22},"obj":"Species"},{"id":"66","span":{"begin":36,"end":44},"obj":"Species"},{"id":"67","span":{"begin":69,"end":77},"obj":"Species"},{"id":"68","span":{"begin":94,"end":102},"obj":"Species"},{"id":"69","span":{"begin":249,"end":253},"obj":"Disease"},{"id":"70","span":{"begin":392,"end":400},"obj":"Disease"},{"id":"71","span":{"begin":872,"end":874},"obj":"Disease"},{"id":"72","span":{"begin":931,"end":934},"obj":"Disease"},{"id":"73","span":{"begin":1025,"end":1030},"obj":"Disease"}],"attributes":[{"id":"A62","pred":"tao:has_database_id","subj":"62","obj":"Gene:7137"},{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"Gene:7137"},{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"Gene:7291"},{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"Tax:9606"},{"id":"A66","pred":"tao:has_database_id","subj":"66","obj":"Tax:9606"},{"id":"A67","pred":"tao:has_database_id","subj":"67","obj":"Tax:9606"},{"id":"A68","pred":"tao:has_database_id","subj":"68","obj":"Tax:9606"},{"id":"A69","pred":"tao:has_database_id","subj":"69","obj":"MESH:D029424"},{"id":"A70","pred":"tao:has_database_id","subj":"70","obj":"MESH:D003920"},{"id":"A71","pred":"tao:has_database_id","subj":"71","obj":"MESH:D001281"},{"id":"A72","pred":"tao:has_database_id","subj":"72","obj":"MESH:D012080"},{"id":"A73","pred":"tao:has_database_id","subj":"73","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Group 2019162 patients Group 202084 patients P value Group I 2019162 patients Group II 202084 patients P value\nAGE 69.9 + 32.6 68.3 + 30.9 ns STEMI 59 (36.4%) 34 (40.5%) ns\nSEX M:113/F:49 M:62/F:22 ns STEMI rr \u003e 24 hours 7 (4.3%) 15 (17.8%) \u003c 0.001\nCOPD 35 (21.6%) 7 (8.3%) \u003c 0.01 NSTEMI 93 (57.4%) 33 (39.3%) \u003c 0.01\nHYPERTENSION 108 (66.7%) 65 (77.4%) ns Others ACS 3 (1.9%) 2 (2.4%) \u003c 0.01\nDIABETES 48 (29.6%) 31 (36.9%) ns Door to balloon (STEMI) 40 + 12 (minutes) 66 + 17 (minutes) \u003c 0.001\nSMOKING 85 (52.5%) 34 (40.5%) ns Symptoms to PCI (STEMI) 3.9 + 2.2 (hours) 5.8 + 3.1 (hours) \u003c 0.001\nDYSLIPIDEMIA 100 (61.7%) 58 (69%) ns Symptoms to PCI (NSTEMI) 18.8 + 20 (hours) 36.9 + 38.4 (hours) \u003c 0.001\nBMI \u003e 30 36 (22.2%) 23 (27.4%) ns hs-cTnI (basal) 1142 + 4017 5138 + 9408 \u003c 0.001\nKNOWN CAD 41 (25.3%) 31 (36.9%) ns hs-cTnI (peak) 9143 + 13,825 13,681 + 10,936 \u003c 0.01\nAF 18 (11.1%) 6 (7.1%) ns LVEF 48.9 + 9.4 45.9 + 12 \u003c 0.05\nCKD 21 (13%) 12 (14.3%) ns LVEF \u003c 40% 24.7% 42.8% \u003c 0.01\nGRACE SCORE 116 + 26 126 + 27 \u003c 0.01 Death 1.8% 4.7% ns"}